Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Leading Health Care Stock for Small-Cap Stars is Arrowhead Research Corp (ARWR) for July 29

ARWR

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.

Here are today's top performing health care Small-Cap Stars:

Arrowhead Research Corp (ARWR)

Arrowhead Research Corp gained 11.47% to $11.95. The gains came on a volume of 6,423,680 shares against an average daily volume of 2,063,415 shares. Arrowhead Research Corp has had a trading range from $27.63 to $3.10 over the last year, it has a 50-day SMA of $12.80, and a 200-day SMA of $12.96.

Arrowhead Research Corp is a biopharmaceutical company developing targeted RNAi therapeutics.

Stemline Therapeutics Inc. (STML)

Stemline Therapeutics Inc. gained 10.92% to $12.80. The gains came on a volume of 148,124 shares against an average daily volume of 130,040 shares. Stemline Therapeutics Inc. has had a trading range from $47.25 to $10.68 over the last year, it has a 50-day SMA of $14.00, and a 200-day SMA of $20.52.

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Zeltiq Aesthetics Inc. (ZLTQ)

Zeltiq Aesthetics Inc. gained 8.64% to $16.59. The gains came on a volume of 664,260 shares against an average daily volume of 455,218 shares. Zeltiq Aesthetics Inc. has had a trading range from $24.79 to $5.87 over the last year, it has a 50-day SMA of $15.88, and a 200-day SMA of $17.05.

ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as CoolSculpting system which is a non-invasive product for the selective reduction of body fat.

Cardionet Inc. (BEAT)

Cardionet Inc. gained 8.22% to $7.37. The gains came on a volume of 652,673 shares against an average daily volume of 378,869 shares. Cardionet Inc. has had a trading range from $11.98 to $5.44 over the last year, it has a 50-day SMA of $7.16, and a 200-day SMA of $8.61.

BioTelemetry Inc provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services.

Raptor Pharmaceutical Corp. (RPTP)

Raptor Pharmaceutical Corp. gained 6.03% to $8.62. The gains came on a volume of 293,934 shares against an average daily volume of 594,969 shares. Raptor Pharmaceutical Corp. has had a trading range from $17.72 to $7.12 over the last year, it has a 50-day SMA of $9.85, and a 200-day SMA of $12.09.

Raptor Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases.

Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio

No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.

Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.

All data provided by QuoteMedia and was accurate as of 4:30 pm ET.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today